TRAV32

Across TCGA pan-cancer cohorts, TRAV32 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated TRAV32 data layer.

The strongest signal is observed in acute myeloid leukemia (LAML), where higher TRAV32 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated TRAV32 expression acts as an unfavorable survival marker, although some lineages such as LAML and LGG show a favorable association.

LAML, READ, and LGG are the cancer types where TRAV32 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LAML	DFS	Tertile	All	0.542	0.287	.001	36	view →
READ	DFS	Tertile	II,III,IV	0.027	0.818	<.001	27	view →
LGG	DFS	Tertile	All	0.682	0.366	.003	18	view →
STAD	OS	Tertile	IV	0.111	0.433	.002	9	view →
BLCA	DFS	Tertile	IV	0.094	0.466	.013	9	view →
SARC	DFS	Tertile	All	0.205	0.634	.038	9	view →
OV	OS	Tertile	IV	1.000	0.578	.015	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

TRAV32–LAML (DFS)

Open the LAML breakdown →